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Abstract
Human sperm DNA damage may have adverse effects on reproductive outcome. Infertile men
possess substantially more spermatozoa with damaged DNA compared to fertile donors. Although
the extent of this abnormality is closely related to sperm function, the underlying etiology of
ensuing male infertility is still largely controversial. Both intra-testicular and post-testicular events
have been postulated and different mechanisms have been proposed to explain the presence of
damaged DNA in human spermatozoa. Three among them, i.e. abnormal chromatin packaging,
oxidative stress and apoptosis, are the most studied and discussed in the present review.
Furthermore, results from numerous investigations are presented, including our own findings on
these pathological conditions, as well as the techniques applied for their evaluation. The crucial
points of each methodology on the successful detection of DNA damage and their validity on the
appraisal of infertile patients are also discussed. Along with the conventional parameters examined
in the standard semen analysis, evaluation of damaged sperm DNA seems to complement the
investigation of factors affecting male fertility and may prove an efficient diagnostic tool in the
prediction of pregnancy outcome.
Background
Sperm chromatin maturity and DNA integrity are neces-
sary prerequisites for the completion of fertilization and
subsequent embryo development [1]. Although an impor-
tant level of sperm nuclear DNA damage can be detected
in men with normal semen parameters, this is higher in
infertile patients attending reproductive clinics and prom-
inent among barely fertile older men [2]. Sperm DNA
damage may be attributed to abnormal chromatin pack-
aging, oxidative stress or poor DNA integrity [3]. Many
studies combining standard semen analysis data with
direct or indirect methods for the assessment of sperm
DNA integrity and the evaluation of the DNA Fragmenta-
tion Index (DFI) from sperm used in ART, showed that
there are threshold values of sperm DNA damage, beyond
which embryo development and pregnancy outcome are
severely compromised [4-12]. Furthermore, sperm DNA
damage thresholds have been proposed in assays applied
to in vivo conditions [4,5,13-15]. Thus, the clinician is
guided as to the therapeutic approach that should be fol-
lowed for the treatment of male infertility, according to
the level of sperm chromatin maturity and DNA integrity
found in the ejaculate [16].
Following a standard semen analysis, men are usually
classified as infertile, sub-fertile or fertile and the World
Health Organization (WHO) has suggested a range of
arbitrary threshold values for human semen parameters,
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such as concentration, motility and morphology, to char-
acterize infertility [17]. Because fertility is not only based
on the absolute number of spermatozoa but also on their
functional capability, additional methods exploring
sperm DNA stability and integrity have been applied dur-
ing the last decade to evaluate fertility disorders and to
increase the predictive value of sperm analysis for procre-
ation in vivo and in vitro [18]. With these new techniques
it was shown that normozoospermic infertile men, in
addition to those having poor semen parameters, have
higher percentages of spermatozoa with DNA fragmenta-
tion compared to the individuals presenting with normal
semen quality [19-23].
Sperm DNA fragmentation may result from aberrant chro-
matin packaging during spermiogenesis [23,24], defective
apoptosis before ejaculation [25,26] or excessive produc-
tion of reactive oxygen species (ROS) in the ejaculate
[20,27,28]. Indeed, in a substantial percentage of infertile
men (about 5%-15%) with complete protamine defi-
ciency, the cause can be attributed to defective chromatin
packaging [29]. Abortive apoptosis during spermatogene-
sis or deficient ligation of transient breaks during sper-
miogenesis may be another reason of sperm DNA damage
[30]. Increased oxidative DNA damage and high levels of
8-hydroxy-2'-deoxyguanosine, a biomarker of oxidized
DNA, have also been detected in the sperm of infertile
men [19] and it has been reported that the likelihood of
pregnancy has been found inversely correlated with 8-
oxo-dG levels [31]. Furthermore, a positive correlation
between sperm DNA fragmentation and ROS generation
have been reported [32]. In a recent paper [3], the authors
suggested that DNA damage of human spermatozoa is
most commonly associated with high levels of ROS,
mainly as a consequence of retained cytoplasmic droplets
on the spermatozoon midpiece. This causes lipid peroxi-
dation of cell membranes, due to the exposure to unsatu-
rated fatty acids and high levels of oxidases, following
spermiogenesis [33]. In addition, human spermatozoa
DNA fragmentation may ensue, following an endonucle-
ase cleavage [34], an activity also affected by oxidative
stress. Therefore, the same cell could be damaged by both
oxidative DNA stress and endonuclease-mediated DNA
fragmentation [3].
Taking into account all these data, the present review
examines abnormal chromatin packaging, oxidative stress
and poor sperm DNA integrity as the possible causes of
male infertility. It attempts to elaborate on results from
numerous studies on these pathological conditions dur-
ing spermatogenesis, spermiogenesis and in the ejacu-
lated spermatozoa. Male genital tract infections and
varicocele as aetiological factors in the generation of ROS
and the consequences in sperm function and fertility are
also discussed. Another chapter of this review elaborates
on the crucial points of each specific technique and their
validity on successful detection of DNA damage as well on
the correlation of their data with fertilization, embryo
development and maintenance of pregnancy. Preliminary
data from our experiments on sperm from oligoasthnote-
ratozoospermic patients, examined with two of these
techniques and discussion on the influence of age on
these parameters are the conclusive points.
Mechanisms
Normal and defective protaminosis
During spermiogenesis (differentiation of the haploid
spermatid to spermatozoon), the chromatin nucleosomal
structure, seen in the interphase nucleus of round sperma-
tids, is extensively modified. Most of the core somatic his-
tones are replaced by sperm specific nuclear proteins,
including transition proteins (TNPs), which are, in turn,
replaced by the more basic protamines [29,35,36]. The
transition proteins are synthesized before the deposition
of the protamines. Four TNPs, TP1 to TP4, have been
identified in humans [37]. These proteins by binding to
DNA destabilize the nucleosomes and maintain the nor-
mal processing of protamines at the same time, thus pro-
moting chromatin condensation [38-40].
Progression of sperm chromatin condensation evolves in
a stepwise manner. The first biochemical change is the
replacement of most of the somatic histones by testis var-
iants [41]. Almost all known histone variants, including
testis-specific histone members, are synthesized before
and during the assembly of transition proteins and pro-
tamines and some are essential in the process of chroma-
tin condensation and genome reorganization [42]. The
initial phase of chromatin starts with hyperacetylation in
the N-terminal histone tails and then other modifications
cause dissociation of nucleosomes, while topoisomerase
II unwinds DNA superhelicity. It is postulated that during
chromatin packaging this endogenous nuclease (topoi-
somerase II) activity is important for the cleavage and
then the ligation of nicks that facilitate protaminosis [43].
These nicks are thought to relieve torsional stress and aid
chromatin rearrangement during the histone to pro-
tamine substitution [43]. Marcon & Boissonneault have
clarified the mechanisms behind DNA folding and have
demonstrated that this ephemeral DNA breakage occurs
in parallel with chromatin remodeling, not only in mouse
but also in human spermatids [44].
The mammalian TNPs are expressed at a high level at mid-
spermiogenesis steps coinciding with chromatin remode-
ling and are involved in the repair of DNA single-strand
breaks (SSB). TP1 can stimulate the repair of SSB in vitro,
as well as the repair of UV-induced DNA lesions in vivo.
The TP1 proteins can participate in the repair process fol-
lowing genotoxic insults and therefore they play an activeReproductive Biology and Endocrinology 2007, 5:36 http://www.rbej.com/content/5/1/36
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role in maintaining the integrity of the male haploid [45].
After massive binding of TNPs to DNA, transcription
ceases. Cessation of transcription is followed by the repair
of DNA breaks and the beginning of the binding of phos-
phorylated protamines. These proteins are of low molecu-
lar mass and are highly basic [46]. Their phosphorylation
facilitates the correct binding to DNA, while increased
condensation of the sperm chromatin is followed by
dephosphorylation.
During the sperm passage in the epididymis, cross-linking
between cysteine residues of protamine disulfide bonds
enhances the stabilization of the nucleoprotamine com-
plex. A healthy mature spermatozoon must decondense
this compact structure upon fertilization and reorganize it
into a nucleosomal structure. Thus, sperm nuclear DNA
organization not only permits the very tightly packaged
genetic information to be transferred safely to the egg, but
it also allows the transformation of this structure into a
more loose configuration so that the genetic information
is easily accessible to the developing embryo [37,47,48].
However, it should be mentioned that some regions of the
DNA retain a nucleosomal structure throughout spermio-
genesis. In humans, about 15% of sperm DNA is associ-
ated with histones or other proteins in a typical
nucleosomal structure. The rest 85% is in the form of a
highly compact nucleoprotamine complex [49-52].
Both transition proteins and protamines are products of
unique genes expressed only in male germ cells [53]. The
protamines are small, basic proteins that package DNA
into a volume twenty fold smaller than the nucleus of
somatic cells [54]. Most mammals have only one pro-
tamine gene but mice, humans and few other mammals
have two sets for each one of protamines P1 and P2. From
the human sperm nucleus a group of four protamines
(HP1, HP2, HP3, and HP4) have been isolated: pro-
tamine HP1, member of the P1 family and protamines
HP2, HP3, HP4, members of the P2 family. Protamine P2
performs an essential function in male fertility [55]. Both
protamines are expressed in roughly equal quantities [56].
The mean P1/P2 ratio in human sperm is approximately
1.0 [54,57]. Altered P1/P2 ratios have been shown in the
sperm from some infertile men as well as a P2 deficiency
in mature sperm, whereas protamine abnormalities are
rarely seen in the sperm from fertile men [56,58-62].
Overall, this means that, persistence of chromatin nicks in
the nuclear DNA of the ejaculated spermatozoa may be a
sign of alterations in the repair mechanism during pro-
tamination and/or an incomplete maturation process
during chromatin condensation [24]. In fact, elevated or
diminished protamine 1/protamine 2 ratios have been
observed in some infertile men and are often associated
with severe spermatogenesis defects [63]. Recently, it has
been suggested that evaluation of the P1/P2 ratio may rep-
resent a more accurate sperm functional assay among oth-
ers [64]. Abnormal protamine expression has been
associated with low sperm counts, decreased sperm motil-
ity and morphology, diminished fertilization ability and
increased sperm DNA damage [57,58]. In some cases of
human male infertility P2 is completely absent [61] or the
normal ratio of the two families of protamines is altered
[56,59]. In addition, reduced protamine P2 levels are in
some cases associated with high amounts of P2 precursor
molecules [61]. Furthermore, disruption of sperm nuclear
compaction alters either P2 or P1 gene and the subse-
quent processing from precursors molecules to mature
forms, ensuing in defective sperm function. [65].
Apoptosis
More than 35 years ago, Kerr et al [66], established that
apoptosis is a physiological mechanism of controlled cell
elimination, complementary but opposite to mitosis, nec-
essary for the development of the definite cell populations
and the maintenance of homeostasis of the organism dur-
ing adulthood. This highly conserved process, also called
programmed cell death (PCD), can be initiated or inhib-
ited by a variety of environmental stimuli [66]. Germline
cell death is required during normal development for
proper formation of gametes and serves to control exces-
sive germ cells number by eliminating the surplus during
differentiation. In addition, it can occur in response to
checkpoints and be involved in the removal of dangerous
or damaged cells [67]. PCD in the germline often displays
apoptotic characteristics, such as chromatin condensa-
tion, membrane blebbing, release of cytochrome c from
mitochondria, formation of apoptosome, an Apaf-1/cas-
pase-9 complex, resulting in further downstream caspase
activation, generating substrate cleavage, endonuclease
activation and DNA fragmentation [68].
Apoptosis in the seminiferous epithelium
Germ cell death occurring during normal spermatogene-
sis in mammals has been identified for more than a cen-
tury and estimated to be responsible for the loss of up to
75% of the potential spermatozoal number [69-71]. In
fact, one part of A2–A4 spermatogonia is eliminated by
apoptosis and only 25% of the theoretically expected
number of spermatocytes I is produced from the original
population of spermatogonia A1. Moreover, selective
death of spermatocytes and spermatids frequently occurs
resulting in the elimination of 20% of these cells. Thus, it
seems a natural conclusion that programmed cell death
must play an important role in spermatogenesis. How-
ever, only after the application of in situ 3'-end labeling
techniques to identify DNA fragmentation in each cell
type of the seminiferous epithelium was spontaneous
germ cell death recognized as being due to apoptosis [72-
74]. Several methods such as Hoechst 33258 DNA stain-Reproductive Biology and Endocrinology 2007, 5:36 http://www.rbej.com/content/5/1/36
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ing, TUNEL assay, flow cytometric annexin-V binding,
immunohistochemical detection of apoptotic markers
and others have been employed to identify apoptosis in
spermatogonia, spermatocytes and spermatids in the tes-
tis of men with normal spermatogenesis, in patients with
non-obstructive azoospermia as well as in the ejaculated
spermatozoa [13,75,76]. Testicular spermatozoa have
been reported to exhibit less DNA damage than those
from the ejaculated sample [77].
Apoptosis in ejaculated spermatozoa
Both apoptosis and necrosis are observed in ejaculated
human sperm [23,26,78]. However, it is uncertain
whether ejaculated sperm retains the ability to activate the
apoptotic cascade or whether the detected apoptotic
markers in spermatozoa are, simply, the expression of an
apoptotic process that has began before the event of ejac-
ulation [26]. Moreover, during in vitro processing, sperma-
tozoa can not enter in the apoptotic pathway and they are
eliminated by necrosis [77]. Gorczyca parallels DNA frag-
mentation in sperm to the apoptotic cleavage in the linker
(internucleosomal) sites seen in somatic cells. But such
regions are not present in the ejaculated sperm chromatin
and DNA breakage can not attributed to an apoptotic
event [79,80].
Apoptotic spermatozoa, observed in the conventional
electron microscopy, present the typical morphological
characteristics of apoptosis seen in somatic cells [81].
These characteristics, involving nuclear and cytoplasmic
elements, are consistently seen in the spermatozoa of fer-
tile men, though in reduced numbers, as well as in these
produced by subfertile patients. Nevertheless, a significant
correlation between spermatozoal DNA fragmentation
and apoptotic features has not been established [79]. Sim-
ilarly, no association was found between DNA fragmenta-
tion and other apoptotic markers such as Fas-receptor,
bcl-x, p53 and caspaces, usually seen in somatic cells,
although these markers have also been detected in the
ejaculate of subfertile men [26,79,82,83].
The percentage of spermatozoa with DNA fragmentation
in normal donors and different groups of patients is illus-
trated in figure 1. Gandini et al. found a statistically signif-
icant reduction (P < 0.001) of the percentage of apoptotic
spermatozoa in the semen of healthy men after swim-up
compared to the raw sample (1.2% ± 0.7% after swim-up
compared to 2.5% ± 1.2% seen in fertile donors) [13].
They observed a statistically significant increase of DNA
fragmentation in the semen of patients suffering from var-
ious pathologies including oligoasthenoteratozoosper-
mia (OAT), Hodgkin's disease and testicular cancer [13].
Furthermore, it is known that patients suffering from
Hodgkin's disease, seminoma or testicular embryonic car-
cinoma, have spermatozoa exhibiting a high level of DNA
fragmentation even before radiation therapy and chemo-
therapy, which often renders them completely sterile
[13,82,84].
Oxidative stress
The primary source of ROS in seminal plasma is sperma-
tozoa themselves as well as polymorphonuclear leuko-
cytes. Low levels of ROS are required for normal sperm
function, capacitation and acrosome reaction [85,86]. In
contrast, defective spermatozoa and increased numbers of
infiltrating leukocytes, mainly from inflammation at the
level of testis, epididymis or the prostate, generate high
levels of ROS, exceeding the protective capacity of the
seminal fluid [3,87-89]. The ensuing oxidative stress
increases the possibility of DNA damage, which can result
to sperm dysfunction due to poor sperm quality, loss of
capacity to undergo the acrosome reaction, difficulty in
the fusion of the sperm with the oocyte and diminished
fertility, both in vitro and in vivo [3,87,88].
The peroxidation of unsaturated fatty acids in the sperm
membranes and DNA fragmentation are implicated in the
Frequency of DNA fragmentation in human ejaculated sper- matozoa Figure 1
Frequency of DNA fragmentation in human ejacu-
lated spermatozoa. The percentage of DNA fragmenta-
tion in the above groups was determined using the terminal 
deoxynucleotidyl transferase mediated dUTP-nick end labe-
ling (TUNEL) assay with or without Hoechst 33258 DNA 
staining. The arithmetic means of each group were obtained 
by adding the group's means, when reported by the cited 
studies, and dividing the sum by the number of the cited 
studies that evaluated that group. The Standard Error of each 
group shown in the graph demonstrates the variability 
between the results of the different studies. All five studies 
evaluated normal donors [13, 81, 175, 181, 182]. Three of 
the studies also assessed a group of infertile patients [13, 
175, 181], two evaluated varicocele patients [81, 182], one 
evaluated cryptorchidism patients and two assessed testicu-
lar cancer patients [13, 81].Reproductive Biology and Endocrinology 2007, 5:36 http://www.rbej.com/content/5/1/36
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mechanism by which ROS cause DNA damage and dis-
rupt sperm function [90,91]. The analyses of markers for
oxidative stress and apoptosis showed a significantly pos-
itive correlation between ROS production, oxidative stress
and DNA damage (fragmentation and presence of single
stranded DNA) [32]. Mitochondria, as the basic source of
ROS, are involved in the activation of pro-apoptotic mol-
ecules, DNA fragmentation and apoptosis. While oxida-
tive damage of the mitochondrial DNA leads to reduced
production of ATP affecting reproductive capacity, nuclear
DNA damage is detrimental to the morphology and func-
tion of the sperm [92]. Lopes et al. have shown that ROS
can be the cause of increased DNA fragmentation and
poor-quality semen samples with a higher percentage of
spermatozoa with fragmented DNA than normal fertile
samples, while pre-treatment with antioxidants can
reduce this DNA damage [20]. It is not clear why defective
human spermatozoa generate high levels of ROS,
although an extra-mitochondrial activity, emanating,
probably, from the exposure to the unsaturated fatty acids
cannot be excluded [93].
Genital tract infections and varicocele
Genital tract infections may cause spermatozoal DNA
damage and have been associated with increased levels of
ROS [3]. Varicocele constitutes a serious cause of male
infertility although it is, also, present in 15% of men who
procreate [94]. Though the impact of this disease on sper-
matogenesis is well documented [95] the aetiological
mechanisms are not yet very clear. Infertile men with var-
icocele compared to normal controls which had initiated
a natural pregnancy, showed statistically significant
higher levels of spermatozoal DNA damage, due to high
levels of ROS and elevated intratesticular temperature
[96]. More precisely, they showed a higher DFI (calculated
by the sperm chromatin structure assay-SCSA) and a sig-
nificant increase of ROS (evaluated by chemilumines-
cence), in contrast to the lower total antioxidant capacity
(TAC) (assessed by enhanced chemiluminescence) [95].
Besides infertile men, analogous scores of ROS and TAC,
have been reported in fertile donors with a clinical diag-
nosis of varicocele [97,98]. Not only SCSA evaluation, but
also an estimation of the apoptotic index (AI) by the
TUNEL assay, confirmed the increase of the percentage of
spermatozoa with DNA damage in patients affected by
varicocele compared to normal fertile men [99]. More
recently, the SCD (Sperm Chromatin Dispersion) test has
also been used to discriminate different levels of DNA
fragmentation in semen from patients with various grades
of varicocele compared to fertile donors [100]. ROS may
also be generated inside the seminiferous tubules by the
cytoplasmic droplets retained in immature spermatozoa
[101] and this seems to be a common feature in the sperm
samples from infertile men with varicocele [102,103].
Nevertheless, it could be interesting to add that varicoce-
lectomy diminishes the percentage of spermatozoa with
damaged DNA (evaluated as DD by flow cytometry of
acridine orange-treated spermatozoa), as reported by Zini
et al. [104]. Finally, the increase of intratesticular temper-
ature is another cause of DNA damage, in patients with
varicocele. In fact, it has been shown that testicular hyper-
thermia, both direct or indirect, can cause DNA damage
via an increase in the histone:protamine ratio [12,105].
Age and spermatozoal DNA damage
Advancing paternal age has been associated with a variety
of anomalies, such as diminished semen quality, numeri-
cal and structural chromosomal abnormalities, that can
decrease reproductive capacity and fertility and increase
the frequency of spontaneous abortions [90]. Although
these age-related changes in the male reproductive system
are universally recognized, the question of declining
fecundity with male age remains controversial
[90,106,107]. Moreover, several studies have shown that
older men seem to produce more spermatozoa with dam-
aged DNA [82,91,108,109], emanating from the three
main potential sources: oxidative stress, abortive Fas-
mediated apoptosis or abnormal chromatin packaging
[110].
Does DNA damage appear more frequently in the sperm of older 
men?
Recently, Singh et al. found an increase in sperm double-
stranded DNA breaks and a decrease in apoptosis with age
by using neutral microgel electrophoresis (Comet) and
DNA diffusion assay [91]. The percentage of sperm with
highly damaged DNA, comet extent, DNA break number
and other comet measures were significantly higher in
men aged 36–57 years compared to those aged 20–35
years. However, the percentage of apoptosis was signifi-
cantly lower in the older group [91]. Furthermore, in a
histomorphometric study of 36 men, aged from 61 to 102
years and 10 young men from 29 to 40 years old, evalua-
tion of the aneuploidy rate and DNA fragmentation
revealed a decrease in the number of germinal and Sertoli
cells with age, although, besides individual variations,
spermatogenesis was possible until a very advanced age
(95 years). When spermiogenesis was arrested, an
increased aneuploidy rate in postmeiotic cells was
observed, whereas apoptosis in the spermatozoa was not
increased with age [111]. In addition, several studies have
demonstrated an age-related increase in sperm cells with
double-stranded DNA breaks or poor chromatin packag-
ing [91,109,112-114]. This age-related effect may happen
as older men produce more sperm with fragmented DNA
due to a higher exposure to oxidative stress in their repro-
ductive tracts [32,115]. Oxidative stress can damage
sperm DNA and mitochondrial and nuclear membranes
[116]. Furthermore, the apoptotic function during sper-
matogenesis may be less effective in older males resultingReproductive Biology and Endocrinology 2007, 5:36 http://www.rbej.com/content/5/1/36
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in the accumulation of more spermatozoa with frag-
mented DNA [117,118]. These observations on the differ-
ential effects of age on genomic damage are consistent
with the recent findings of Wyrobek et al. [109], who
reported age-related effects on DNA fragmentation and
achondroplasia mutations but not aneuploidy, Apert syn-
drome mutations or sex chromosome ratio.
In our laboratory, we used the TUNEL assay (Figure 2) and
Chromomycin A3 staining (Figure 3) to assess the aging
effects on the percentages of DNA fragmentation and
chromatin packaging respectively in oligoastheno-
zoospermic patients (Figures 4). Sixty one oligoasthenot-
eratozoospermic patients were divided into two age
subgroups (20–34 years old, n = 30; 35–50 years old, n =
31). Forty nine healthy fertile controls were also divided
according to their age (20–34 years old, n = 26; 35–50
years old, n = 23). In the control group, the differences
observed between the two age subgroups were not statis-
tically significant (P > 0.05; Figure 4A, B). On the other
hand, the older patient subgroup demonstrated a signifi-
cantly higher percentage of TUNEL positive (P < 0.001;
Figures 2, 4A) and CMA3 stained (P < 0.001; Figures 3,
4B) spermatozoa compared to the younger patient sub-
group. In addition, the older donors (35–50 years old, n
= 23) showed significantly lower percentages of TUNEL
positive and CMA3 stained spermatozoa compared to the
younger patient subgroup (20–34 years old, n = 30; P <
0.001). The younger patient subgroup (20–34 years old, n
= 30) demonstrated significantly higher percentages of
TUNEL positive and CMA3 stained spermatozoa com-
pared to the younger donor subgroup (20–34 years old, n
= 26; P < 0.001).
Indeed, the reproductive potential of older couples is
compromised. The above results attest that, in addition to
CMA3 staining Figure 3
CMA3 staining. Two types of staining patterns were identified, bright and dull yellow fluorescence of the sperm nuclei 
(abnormal chromatin packaging) (A, B) and blue staining with DAPI in the healthy nucleus (normal chromatin packaging) seen in 
C.
TUNEL assay Figure 2
TUNEL assay. TUNEL-positive nuclei (with double-strand nuclear DNA fragmentation) of spermatozoa as represented by 
the intense (A) and dull (B) Texas red fluorescence in the nuclear region. The healthy nuclei (without DNA fragmentation) are 
stained blue with DAPI (C) used as counterstain.Reproductive Biology and Endocrinology 2007, 5:36 http://www.rbej.com/content/5/1/36
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the increased abnormalities in conventional semen
parameters [115] and the reduced DNA repair capabili-
ties, other factors are also operating in aged males. This
can also be attributed to an accumulation of DNA-dam-
aged spermatozoa due to a deficient apoptotic machinery.
Thus, the decreased elimination and subsequent accumu-
lation of defective spermatozoa, concomitantly with poor
DNA integrity and abnormal chromatin packaging were
confirmed to be operational in the older male. Many of
these couples seek specialized help from in vitro fertiliza-
tion (IVF) clinics. Following this procedure, the natural
selection of "healthy" sperm will be bypassed and the pos-
sible use of defective spermatozoa may negatively affect
the ART outcome. In some ART centers, semen samples
are prepared immediately prior to their use, in order to
overcome the negative effect of a prolonged time of incu-
bation of a density gradient selected sperm.
Influence of sperm DNA damage on reproductive outcome
Male infertility is associated with poor sperm DNA integ-
rity and it has been suggested that these DNA abnormali-
ties may affect procreation in couples having natural
intercourse and in those treated by IUI, IVF and intracyto-
plasmic sperm injection (ICSI) [119-122]. In addition,
fragmented DNA is a more common finding in couples
having a history of recurrent miscarriages than in those
attempting pregnancy via IVF or donor insemination
[123]. There is also strong clinical evidence that the com-
bination of increased sperm DNA damage with abnormal-
ities in standard semen parameters can have an obvious
impact on the reproductive potential [121,122,124,125].
Furthermore, for a threshold value of DNA fragmentation
above 10%, a significant negative correlation to the ferti-
lization rate has been reported by Benchaib et al. [126].
However, several studies have examined the possible
influence of sperm DNA damage on the reproductive out-
come of both standard IVF and IVF/ICSI, showing no con-
sistent relationship [12,119-122,124,126-134]. Since the
embryonic genome is not expressed until after the second
cleavage division, it is logical to assume that sperm DNA
damage does not affect fertilization or embryo develop-
ment [12,135]. Furthermore, no consistent relationship
seems to exist between sperm DNA damage and embryo
quality after ICSI (approximately half of the studies have
shown an adverse effect) [12]. High levels of sperm DNA
damage, however, are inversely correlated to pregnancy
rates in most of the studies [12,119-122,124,126-134].
The influence of DNA fragmentation index (DFI) on the
fertilization rate and pregnancy outcome varies from
study to study. In one investigation, the highest DFI found
among fertile donors was 24% and has been used for the
classification of infertile men into high (> 24%) and low
(≤ 24%) DNA damage groups [2]. In cases involving ICSI,
the fertilization rate decreased when the DFI was elevated
but, nevertheless, term pregnancies have been obtained
even with high sperm DFI (> 30%) [8]. Furthermore, Virro
et al. found that men with high levels of DNA fragmenta-
tion (≥ 30% DFI) had a significantly lower chance of ini-
tiating a chemical pregnancy compared to men with <
30% DFI, whereas no relationship between high DNA
stainability (HDS) and chemical pregnancies, spontane-
ous abortions or ongoing pregnancies was observed
[121]. Boe-Hansen et al. found that by using spermatozoa
with a DFI > 27%, the probability of a successful preg-
The effect of age on DNA fragmentation and chromatin  packaging Figure 4
The effect of age on DNA fragmentation and chro-
matin packaging. DNA fragmentation was assessed using 
the TUNEL assay, while chromatin packaging was evaluated 
using the chromomycin A3 (CMA3) staining. Sixty one oli-
goasthenoteratozoospermic patients were divided into two 
age subgroups (20–34 years old, n = 30; 35–50 years old, n = 
31). Forty nine healthy fertile controls were also divided 
according to their age (20–34 years old, n = 26; 35–50 years 
old, n = 23). In the control group, the differences observed 
between the two age subgroups were not statistically signifi-
cant (P > 0.05; Figure 4A, 4B). On the other hand, the older 
patient subgroup demonstrated a significantly higher percent-
age of TUNEL positive (P < 0.001; Figure 4A) and CMA3 
stained (P < 0.001; Figure 4B) spermatozoa compared to the 
younger patient subgroup.Reproductive Biology and Endocrinology 2007, 5:36 http://www.rbej.com/content/5/1/36
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nancy may be reduced, although full-term pregnancy can
still be achieved [136]. Evenson and Wixon reported that
semen samples containing ≥ 30% spermatozoa with frag-
mented DNA were found inappropriate to achieve preg-
nancy [16]. In another study, the prognostic value of
sperm DNA fragmentation levels in predicting IVF and
ICSI outcome was determined in 85 couples. An inverse
correlation between the percentage of spermatozoa with
fragmented DNA and fertilization rate, synchronization
of the "nucleolar precursor bodies" pattern in pronuclei,
blastocyst development and embryo quality was reported
[137].
Overall, DFI levels higher than 15% can multiply the risk
of miscarriage fourfold (37.5% versus 8.8%) and worsen
the prognosis for pregnancy [138]. Moreover, in the larg-
est study on the predictive value of SCSA in relation to the
outcome of ART by Bungum et al. it was shown that if DFI
exceeds 30%, ICSI should be the preferred approach even
in cases where traditional sperm parameters are normal
[139]. In this same study it was also reported that in
almost 20% of the patients DFI was found > 30%,
although semen parameters fulfilled the criteria for either
IUI or IVF. Furthermore, no statistically significant associ-
ation between high DFI and early pregnancy loss was
observed, contrasting previous reports that reported an
increased risk of embryonic loss in pregnancies achieved
by the use of semen samples with high rates of DNA
breaks [121,123], However, the possibility that DFI levels
higher than 60% might be associated with an increased
risk of early pregnancy loss could not be excluded.
Methods used to assess DNA damage
Detection of DNA fragmentation
Many assays, both direct and indirect, are used for detect-
ing DNA breaks (Table 1). Direct methods include: i) the
deoxynucleotidyl transferase-mediated dUTP nick end
labeling (TUNEL) assay [22,23,84], ii) the single-cell gel
electrophoresis assay (Comet assay) [140-142] and iii) the
in situ nick translation assay with or without sperm
decondensation [19,143], whereas the indirect methods
include: i) Acridine Orange Technique (AOT), first intro-
duced by Teyada RI et al. [144] and ii) Sperm Chromatin
Structure Assay (SCSA) [145].
Principle and use of each technique
The TUNEL assay detects both single- and double-
stranded DNA fragments by labelling the 3'-OH termini
with a fluorescently labelled nucleotide (dUTP) in an
enzymatic reaction driven by terminal deoxynucleotidyl
transferase (TdT) [79]. This technique was first described
by Gavrieli et al. [146] and used to detect DNA strand
breaks in mammalian spermatozoa. The percentage of
spermatozoa with fragmented DNA is determined by
direct observation using an epifluorescence microscope or
by using flow cytometry. Hence, the TUNEL technique has
been used in numerous studies [9,13,32,68,147,148]. In
one of them it has been demonstrated that the fractions of
low sperm motility from ejaculates of infertile men
showed a relatively high proportion of cells with DNA
fragmentation [31]. Another study, undertaken to analyze
the possible relationship between ART failure and sperm
DNA fragmentation, revealed high percentages of sperma-
tozoa with fragmented DNA often found in cases of
repeated ART failures [148]. Finaly, Sergerie et al demon-
strated that infertile patients have a higher mean level of
DNA fragmentation compared to men of proven fertility
[9].
The nick translation technique measures the incorpora-
tion of radiolabelled thymidine in the 3' ends of broken
DNA strands by monitoring the activity of the DNA
Table 1: Sperm chromatin damage assays
Assays for the evaluation of sperm 
chromatin maturity/DNA integrity
Assay Principle References




mediated dUTP- nick end labelling – TUNEL
DNA fragmentation, single and double-strand 
breaks
[22, 23, 80, 175, 183]
Acridine Orange Technique (AOT) Distinguish between single and double stranded 
DNA
[144, 147, 148, 170, 184, 185]
Sperm Chromatin Structure Assay (SCSA) Acid DNA denaturation [145, 151]
In situ nick translation Single-strand DNA breaks [19, 143, 150]
Sperm chromatin dispersion test (SCD) Determines the susceptibility of sperm DNA to 
acid denaturation
[163]
DNA diffusion assay Alkali-labile sites in alkaline conditions yield 
low- molecular-weight DNA fragments
[164]
Acidic Aniline Blue Stains lysine residues of persisting histones [60, 166, 167, 169, 170]
Toluidine blue stain DNA structure and chromatin packaging, 
incorporates in the damaged dense chromatin
[165, 185]
Chromomycin A3 – CMA3 Indirect visualization of nicked denatured DNA [149, 171, 172]Reproductive Biology and Endocrinology 2007, 5:36 http://www.rbej.com/content/5/1/36
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polymerase I enzyme and revealing by radioautography
the "laddering" pattern of the resulting fragments. Alter-
natively, nucleotides labeled with biotin or digoxigenin
can also be used for incubation with DNA polymerase I.
The template-dependent enzyme (DNA polymerase I) in
the presence of DNA nicks, by virtue of its 5'-3' exonucle-
otic activity, catalyzes the movement of the nicks along
the double helix [149,150].
The Comet assay involves embedding of spermatozoa in
agarose on a glass slide, applying electrophoresis and eval-
uating DNA migration in comet tails with a software pro-
gram [145,151]. It is a simple, rapid and sensitive
technique for the assessment and quantification of DNA
damage in individual cells, first introduced by Östling and
Johanson in 1984 [152] as a neutral assay in which the
lysis and electrophoresis were done under neutral condi-
tions. Subsequently, Singh et al, introduced a microgel
technique involving electrophoresis under alkaline (pH
13) conditions for detecting DNA damage in single cells
[153] and Haines et al. detected DNA damaged spermato-
zoa after in vitro irradiation [154].
Regarding the indirect methods, both the acridine orange
technique (AOT) and the sperm chromatin structure assay
(SCSA) are used to measure the susceptibility of sperm
DNA to acid-induced denaturation [144]. Normal dou-
ble-stranded DNA stains green and single-stranded DNA
stains red in AOT [155,156], a simple microscopic proce-
dure that comes with its own set of problems, while SCSA
uses flow cytometry [145,151]. The percentage of DNA
fragmentation, also referred to as DNA Fragmentation
Index (DFI) is yielded by the ratio of red/red+green. The
percentage of sperm showing > 56% red fluorescence is
considered as the "cut-off" value to characterize an abnor-
mal chromatin status [157-159]. In situ detection of sperm
DNA damage using automated instrumentation (flow
cytometers) was described for the first time in 1980 [160].
Evenson  et al. [145] later refined the SCSA protocol.
Although AOT and SCSA are based on the same principle
and use the same chromatin intercalating metachromatic
dye acridine orange, several differences between them
have been reported [161]. Furthermore, SCSA and AOT
have been compared by running the 2 techniques on the
same human samples and in both cases, the results were
not significantly associated [162].
Recently, novel clinical tests for DNA fragmentation and
apoptosis were introduced, such as the Sperm Chromatin
Dispersion test (SCD) that determines the susceptibility
of sperm DNA to acid denaturation and the DNA diffu-
sion assay [163,164]. The SCD test principle is that sperm
with fragmented DNA fails to produce the characteristic
halo of dispersed DNA loops observed in sperm with dou-
ble-stranded DNA following acid denaturation and
removal of nuclear proteins. The DNA diffusion assay is a
simple and reproducible test based on the principle that
apoptotic cells have numerous alkali-labile sites which,
once exposed to alkaline conditions, yield low-molecular-
weight DNA fragments. These pieces are easily diffusable
in the agarose matrix, giving a characteristic pattern of
DNA gradient, with the appearance of a hazy halo around
the apoptotic cells.
Several researchers have shown that sperm DNA denatur-
ation, as measured by the SCSA test, is strongly correlated
with other DNA damage biomarkers such as TUNEL and
Comet assays [10,21,140]. Nevertheless, the SCSA analy-
sis is considered by some investigators to be the most reli-
able test, needed in a clinical setting to help manage a
couple's infertility treatment, while the Comet and
TUNEL assays lack the precision, consistency and repro-
ducibility necessary to this end [16]. Conversely, others
believe that DNA fragmentation can be successfully
detected with SCSA, TUNEL, and SCD yielding similar
results, in respect to accuracy and sensitivity [162].
Sperm nuclear maturity tests
These tests measure the sperm chromatin packaging qual-
ity and the protamine content directly, through pro-
tamine extraction and polyacrylamide gel electrophoresis
(PAGE), or indirectly. Toluidine blue staining was first
described by Krzanowska H. in 1982 [165]. Assays using
aniline blue or toluidine blue are applied to detect the
lysine-rich nucleoproteins (histones) and, therefore, give
an indication of the presence of lower amounts of pro-
tamines in the sperm nucleus [60,166]. Asthenozoosper-
mic semen samples show increased percentage of aniline
blue cells compared to normozoospermic samples [167].
Acidic aniline blue has also been correlated with differ-
ences in sperm nuclear morphology in sperm donors and
in infertile patients [168,169]. Furthermore, the persist-
ence of lysine-rich nucleoproteins revealed by acidic ani-
line blue staining correlates positively with acridine
orange [170] and chromomycin A3  staining [171].
A polymerase inhibitor, CMA3, is used in another indirect
approach for the evaluation of normal protaminosis. This
test was fist described by Hayasaka T and Inoue Y in 1969
[172]. Based on the in situ competition between pro-
tamine and CMA3, this assay is inversely correlated with
the protamination state of spermatozoa [173]. This means
that incorporation of CMA3 can prevent the accessibility
of DNA polymerase I to the DNA and, almost none of the
CMA3- negative spermatozoa present nicked DNA, as
CMA3 is unable to access DNA in the presence of pro-
tamines and normally formed disulphide bonds
[24,149,174]. CMA3 staining is evaluated by distinguish-
ing between spermatozoa nuclei with bright or dull yel-
low staining (CMA3 positive) compared to spermatozoaReproductive Biology and Endocrinology 2007, 5:36 http://www.rbej.com/content/5/1/36
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nuclei counterstained blue with DAPI (CMA3 negative) as
shown in figure 4. Normozoospermic men demonstrate a
lower percentage of spermatozoa with DNA damage and
CMA3 positivity compared with oligozoospermic and ter-
atozoospermic men. Moreover, patients that do not estab-
lish a pregnancy show an increased percentage of DNA-
damaged spermatozoa [129,174].
The hypothesis that the presence of DNA damage in
mature spermatozoa is correlated to poor chromatin
packaging [19] is supported by the results of Mantas et al.
[175], who showed a significant positive correlation
between DNA fragmentation (TUNEL assay) and chroma-
tin packaging (CMA3 staining) in men with low semen
quality. Correlations between CMA3 staining, sperm mor-
phology, fertilization and assisted reproduction outcome
have been found in patients undergoing routine IVF, sub-
zonal insemination (SUZI) or ICSI [176-179]. Thus,
CMA3 is a useful tool for evaluating infertile patients as it
will stain decondensed, protamine-depleted spermato-
zoa. However, CMA3  staining cannot discriminate
whether the potential protamine deficiency is due to a
lack of P1, P2 or a combination of both [62]. This disad-
vantage can be resolved by measuring protamines P1 and
P2 directly by gel electrophoresis. In fact a significant neg-
ative correlation of the fertilization rate with the pro-
tamine deficiency and the P1/P2 ratio was found using
this approach [180].
Conclusion
Analysing the impact of specific biomarkers of protami-
nosis and sperm DNA integrity, it becomes apparent that
their use as indicators associated with normal chromatin
packaging and normal semen parameters can assist in
eliminating the risk of using spermatozoa with defective
DNA and, thus, lead to the improvement of male fertility,
successful conception and pregnancy outcome. Although,
an important level of sperm DNA damage can also be
detected in fertile men this is more pronounced in infer-
tile men attending reproductive clinics, especially among
older men whose reproductive potential is compromised.
Beyond the increased abnormalities in conventional
semen parameters and the reduced DNA repair capabili-
ties, this can also be attributed to an accumulation of
DNA-damaged spermatozoa due to deficient apoptotic
machinery. Thus, the decreased elimination and subse-
quent accumulation of defective spermatozoa, concomi-
tantly with poor DNA integrity and abnormal chromatin
packaging, result in a sperm of poor quality. Injecting
these abnormal spermatozoa into oocytes will probably
result in failure of sperm decondensation and fertiliza-
tion, as there appears to be a threshold value of sperm
DNA damage beyond which embryo development and
subsequent pregnancy outcome are impaired. Therefore,
detection of damaged DNA in spermatozoa needs to be
conducted along with standard semen analysis. Assess-
ment of the results from various techniques on this issue
could be a very efficient diagnostic tool for the evaluation
of the underlying pathologies. In addition, large-scale
studies in different clinical settings may be useful to
explain the presence of defective DNA in patients with
unexplained infertility and to determine the effects of
sperm DNA damage on the outcome of ART.
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